findmyKOL
Clinical trialNCT00624923CompletedPhase 2/PHASE3Interventional

Targeting Inflammation Using Salsalate in CardioVascular Disease

SponsorJoslin Diabetes CenterEnrollment340Coronary Artery DiseaseOverweight
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Seacoast Cardiology

    York Village, Maine, United States

  • Joslin Diabetes Center

    Boston, Massachusetts, United States

  • Heart Center of Metrowest

    Framingham, Massachusetts, United States

  • South Shore Internal Medicine

    Milton, Massachusetts, United States

  • Newton-Wellesley Cardiology

    Newton, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2008
Primary completion
31 Jan 2015
Completion
31 Jul 2016
Last update posted
7 May 2019
Registered enrollment
340
Registry id
NCT00624923

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.